Human Platelet Lysate Market Set to Skyrocket Past $550 Million by 2032: The Engine Powering Next-Gen Cell and Gene Therapies
The global biotechnology landscape is witnessing a seismic shift driven by the rapid commercialization of advanced therapies, particularly in the fields of cell and gene therapy. At the heart of this revolution is Human Platelet Lysate (HPL), an indispensable growth supplement for *in vitro* cell culture. HPL, a rich cocktail of growth factors, cytokines, and essential nutrients derived from...
0 Commentaires 0 Parts 559 Vue 0 Aperçu
MTSocial https://mtsocial.ir